Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Kolak, Maria ^a   Gertow, Joanna ^a   Westerbacka, Jukka ^b   Summers, Scott A ^c   Liska, Jan ^a   Franco Cereceda, Anders ^a   Orešič, Matej ^d   Yki Järvinen, Hannele ^b   Eriksson, Per ^a   Fisher, Rachel M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

Adipose tissue; Ceramide; Human; Inflammation; Sphingomyelinase

Indexed keywords

CD68 ANTIGEN; CERAMIDE; INTERLEUKIN 6; MESSENGER RNA; SPHINGOMYELIN PHOSPHODIESTERASE; VASCULOTROPIN;

ABDOMINAL FAT; ADULT; AGED; ARTICLE; CATALYSIS; CLINICAL ARTICLE; ENZYME METABOLISM; ENZYME SYNTHESIS; FAT CONTENT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INFLAMMATION; LIPIDOMICS; MACROPHAGE; MALE; OBESITY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SUBCUTANEOUS FAT; VASCULAR ENDOTHELIUM;

EID: 84867864932     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-115     Document Type: Article

References (35)

1. Obesity is associated with macrophage accumulation in adipose tissue. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr, J Clin Invest 2003 112 1796 1808 14679176 (Pubitemid 38063703)
2. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, Wang S, Fortier M, Greenberg AS, Obin MS, J Lipid Res 2005 46 2347 2355 10.1194/jlr.M500294-JLR200 16150820 (Pubitemid 41532523)
3. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Kolak M, Westerbacka J, Velagapudi VR, Wågsäter D, Yetukuri L, Makkonen J, Rissanen A, Hakkinen AM, Lindell M, Bergholm R, et al. Diabetes 2007 56 1960 1968 10.2337/db07-0111 17620421 (Pubitemid 47195815)
4. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Goossens GH, Physiol Behav 2008 94 206 218 10.1016/j.physbeh.2007.10.010 18037457 (Pubitemid 351615418)
5. The obese healthy paradox: is inflammation the answer? Barbarroja N, Lopez-Pedrera R, Mayas MD, Garcia-Fuentes E, Garrido-Sanchez L, Macias-Gonzalez M, El Bekay R, Vidal-Puig A, Tinahones FJ, Biochem J 2010 430 141 149 10.1042/BJ20100285 20522023
6. The fatty liver and insulin resistance. Yki-Jarvinen H, Westerbacka J, Curr Mol Med 2005 5 287 295 10.2174/1566524053766031 15892648 (Pubitemid 40667509)
7. Ceramides in insulin resistance and lipotoxicity. Summers SA, Prog Lipid Res 2006 45 42 72 10.1016/j.plipres.2005.11.002 16445986 (Pubitemid 43170804)
8. Principles of bioactive lipid signalling: lessons from sphingolipids. Hannun YA, Obeid LM, Nat Rev Mol Cell Biol 2008 9 139 150 10.1038/nrm2329 18216770 (Pubitemid 351158911)
9. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Holland WL, Summers SA, Endocr Rev 2008 29 381 402 10.1210/er.2007-0025 18451260 (Pubitemid 351831506)
10. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, DeFronzo RA, Kirwan JP, Diabetes 2009 58 337 343 19008343
11. Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Straczkowski M, Kowalska I, Baranowski M, Nikolajuk A, Otziomek E, Zabielski P, Adamska A, Blachnio A, Gorski J, Gorska M, Diabetologia 2007 50 2366 2373 10.1007/s00125-007-0781-2 17724577 (Pubitemid 47512392)
12. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, Bui HH, Davis KE, Bikman BT, Halberg N, Rutkowski JM, et al. Nature Med 2011 17 55 63 10.1038/nm.2277 21186369
13. Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. de Mello V, Lankinen M, Schwab U, Kolehmainen M, Lehto S, Seppänen-Laakso T, Oreic M, Pulkkinen L, Uusitupa M, Erkkilä AT, Diabetologia 2009 52 2612 2615 10.1007/s00125-009-1482-9 19669729
14. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. Holland WL, Bikman BT, Wang L-P, Yuguang G, Sargent KM, Bulchand S, Knotts TA, Shui G, Clegg DJ, Wenk MR, et al. J Clin Invest 2011 121 1858 1870 10.1172/JCI43378 21490391
15. Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. Shah C, Yang G, Lee I, Bielawski J, Hannun YA, Samad F, J Biol Chem 2008 283 13538 13548 10.1074/jbc.M709950200 18359942
16. Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation. Van Eijk M, Aten J, Ottenhoff R, Van Roomen CPAA, Dubbelhuis PF, Seeman I, Ghauharali-VanDer Vlugt K, Overkleeft HS, Arbeeny C, Groen AK, et al. PLoS One 2009 4 4723 10.1371/journal.pone.0004723 19305508
17. Aging up-regulates expression of inflammatory mediators in mouse adipose tissue. Wu D, Ren Z, Pae M, Guo W, Cui X, Merrill AH, Nikbin Meydani S, J Immunol 2007 179 4829 4839 17878382
18. Central leptin regulates total ceramide content and sterol regulatory element binding protein-1c proteolytic maturation in rat white adipose tissue. Bonzán-Kulichenko E, Schwudke D, Gallardo N, Moltá E, Fernández-Agullá T, Shevchenko A, Andrés A, Endocrinology 2009 150 169 178 18801905
19. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Yang G, Badeanlou L, Bielawski J, Roberts AJ, Hannun YA, Samad F, Am J Physiol Endocrinol Metab 2009 297 211 E224 10.1152/ajpendo.91014.2008 19435851
20. Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance. Blachnio-Zabielska AU, Koutsari C, Tchkonia T, Jensen MD, Obesity 2012 Epub 7 June 2012
21. Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease. Folkersen L, Van't Hooft F, Chernogubova E, Agardh HE, Hansson GK, Hedin U, Liska J, Syvanen AC, Paulsson-Berne G, Franco-Cereceda A, et al. Circ Cardiovasc Genet 2010 3 365 373 10.1161/CIRCGENETICS.110.948935 20562444
22. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Westerbacka J, Kolak M, Kiviluoto T, Arkkila P, Sirén J, Hamsten A, Fisher RM, Yki-Järvinen H, Diabetes 2007 56 2759 2765 10.2337/db07-0156 17704301 (Pubitemid 350044919)
23. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. Yen CL, Stone SJ, Koliwad S, Harris C, Farese RV Jr, J Lipid Res 2008 49 2283 2301 10.1194/jlr.R800018-JLR200 18757836
24. Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein. Romeo S, Huang-Doran I, Baroni MG, Kotronen A, Curr Opin Lipidol 2010 21 247 252 10.1097/MOL.0b013e328338ca61 20480550
25. nSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosis. Levy M, Castillo SS, Goldkorn T, Biochem Biophys Res Commun 2006 344 900 905 10.1016/j.bbrc.2006.04.013 16631623
26. Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis. Claus RA, Bunck AC, Bockmeyer CL, Brunkhorst FM, Losche W, Kinscherf R, Deigner HP, FASEB J 2005 19 1719 1721 16051685 (Pubitemid 41429541)
27. Altered adipose and plasma sphingolipid metabolism in obesity. A potential mechanism for cardiovascular and metabolic risk. Samad F, Hester KD, Yang G, Hannun YA, Bielawski J, Diabetes 2006 55 2579 2587 10.2337/db06-0330 16936207 (Pubitemid 44871159)
28. Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Håversen L, Danielsson KN, Fogelstrand L, Wiklund O, Atherosclerosis 2011 202 382 393
29. Ceramide metabolism is affected by ovesity and diabetes in human adipose tissue. Blachnio-Zabielska AU, Pulka M, Baranowski M, Nikolajuk A, Zabielski P, Gárska M, Gárski J, J Cell Physiol 2012 227 550 557 10.1002/jcp.22745 21437908
30. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix. Marathe S, Kuriakose G, Williams KJ, Tabas I, Arterioscler Thromb Vasc Biol 1999 19 2648 2658 10.1161/01.ATV.19.11.2648 10559007 (Pubitemid 29536039)
31. Fatty liver, insulin resistance, and dyslipidemia. Adiels M, Taskinen MR, Boren J, Curr Diab Rep 2008 8 60 64 10.1007/s11892-008-0011-4 18367000 (Pubitemid 351384877)
32. Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum. Kotronen A, Seppänen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, Ruskeepää A-L, Yki-Jarvinen H, Oreic M, Obesity 2010 18 937 944 10.1038/oby.2009.326 19798063
33. Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Pang C, Gao Z, Yin J, Zhang J, Jia W, Ye J, Am J Physiol Endocrinol Metab 2008 295 313 E322 10.1152/ajpendo.90296.2008 18492768
34. Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction. Cogolludo A, Moreno L, Frazziano G, Moral-Sanaz J, Menendez C, Castãeda J, González C, Villamor E, Perez-Vizcaino F, Cardiovasc Res 2009 82 296 302 19088082
35. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death. Van Brockyln JR, Williams JB, Comp Biochem Physiol B Biochem Mol Biol 2012 163 26 36 10.1016/j.cbpb.2012.05.006 22613819